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The SCL transcription factor is critically important for vertebrate hematopoiesis and angiogenesis, and has been postulated to induce
hemangioblasts, bipotential precursors for blood and endothelial cells. To investigate the function of scl during zebrafish hematopoietic and
endothelial development, we utilized site-directed, anti-sense morpholinos to inhibit scl mRNA. Knockdown of scl resulted in a loss of
primitive and definitive hematopoietic cell lineages. However, the expression of early hematopoietic genes, gata2 and lmo2, was unaffected,
suggesting that hematopoietic cells were present but unable to further differentiate. Using gene expression analysis and visualization of vessel
formation in live animals harboring an lmo2 promoter-green fluorescent protein reporter transgene (Tg(lmo2:EGFP)), we show that
angioblasts were specified normally in the absence of scl, but later defects in angiogenesis were evident. While scl was not required for
angioblast specification, forced expression of exogenous scl caused an expansion of both hematopoietic and endothelial gene expression, and
a loss of somitic tissue. In cloche and spadetail mutants, forced expression of scl resulted in an expansion of hematopoietic but not
endothelial tissue. Surprisingly, in cloche, lmo2 was not induced in response to scl over-expression. Taken together, these findings support
distinct roles for scl in hematopoietic and endothelial development, downstream of hemangioblast development.
D 2004 Elsevier Inc. All rights reserved.
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Hematopoiesis is a dynamic process that occurs in
successive stages and distinct anatomical locations during
the vertebrate life span (reviewed in Galloway and Zon,
2003). In zebrafish, the first wave of hematopoiesis, termed
primitive or embryonic, occurs in two distinct regions of the
lateral mesoderm. In the posterior mesoderm, bilateral stripes
of both erythroid and endothelial precursors migrate toward
the midline of the embryo to form the intermediate cell mass0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.09.004
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URL: http://zon.tchlab.org/.(ICM), which is the equivalent of the extraembryonic
mammalian yolk sac blood islands. The endothelial precur-
sors form discrete axial vessels, and surround the inner mass
of proliferating erythroblasts that enter circulation by
approximately 28 h post-fertilization (hpf). A second site of
primitive hematopoiesis occurs within the anterior lateral
mesoderm, in close association with endothelial precursors,
and gives rise to macrophages and granulocytes (Bennett et
al., 2001; Herbomel et al., 1999; Lieschke et al., 2002).
Lineage-specific genes, such as l-plastin and gata1, are
restricted to the anterior myeloid or posterior erythroid
populations, respectively (Bennett et al., 2001; Herbomel et
al., 1999; Lieschke et al., 2002). In contrast to the transient
primitive wave, definitive hematopoiesis generates long-term
hematopoietic stem cells (HSCs) that continuously provide
erythroid, myeloid, and lymphoid lineages throughout adult-
hood. Definitive hematopoiesis in the zebrafish is thought to277 (2005) 522–536
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occurs in presumptive definitive HSC along the ventral wall
of the dorsal aorta (Burns et al., 2002; Kalev-Zylinska et al.,
2002; Thompson et al., 1998). This site is analogous to the
origin of definitive HSCs in the mammalian aorta-gonad-
mesonephros (AGM) region (Jaffredo et al., 1998; Medvin-
sky and Dzierzak, 1996; North et al., 2002). Zebrafish
lymphoid precursors expressing the T-cell-specific genes,
recombination activating gene-1 and-2 (rag1 and rag2)
(Willett et al., 1999) are found in the thymus as early as 3 dpf.
By 5 dpf, hematopoietic expression occurs in the kidney
primordia, which will become the site of adult zebrafish
hematopoiesis (Al-Adhami and Kunz, 1977; Zapata, 1979).
The scl gene encodes a basic helix–loop-helix tran-
scription factor (Begley et al., 1990; Chen et al., 1990;
Finger et al., 1989) and is a key regulatory molecule in
hematopoietic development. Gene targeting studies and
chimeric analyses in mice demonstrate that scl is essential
for the generation of all primitive and definitive hema-
topoietic lineages (Porcher et al., 1996; Robb et al., 1995,
1996; Shivdasani et al., 1995). The scl gene is also
expressed in endothelial cells (Hwang et al., 1993;
Kallianpur et al., 1994), and the expression in both cell
types has suggested a possible role for scl in specification
of the hemangioblast, a bipotential precursor for both
hematopoietic and endothelial cells. Historically, the
existence of a hemangioblast was hypothesized due to the
close association of both cell types during avian embryonic
development (Murray, 1932; Sabin, 1920). More recently,
hematopoietic and endothelial precursors were shown to
develop in cell culture from a single blast colony forming
cell (BL-CFC), thus representing an in vitro equivalent of
the hemangioblast (Choi et al., 1998). Although scl
expression occurs in endothelial cell types, Scl/ mice
have normal angioblast specification, and only display later
defects in vascular remodeling (Robb et al., 1995;
Shivdasani et al., 1995; Visvader et al., 1998). These
findings are consistent with in vitro studies in which Scl/
murine ES cells, following differentiation, are unable to
generate hematopoietic precursors, but can generate adher-
ent, flk1+endothelial cells (Elefanty et al., 1997; Robertson
et al., 2000). Based on these observations, it can be
concluded that murine Scl is not required for hemangioblast
specification.
Transcripts for zebrafish scl appear at approximately the
2- to 3-somite stage in erythroid and endothelial precursors
in the posterior lateral mesoderm and in myeloid and
endothelial precursors in the anterior lateral mesoderm
(Gering et al., 1998; Liao et al., 1998). Analyses in vitro
have demonstrated that SCL functions in a multimeric
transcriptional complex with LMO2, a LIM-only protein
(Wadman et al., 1997; Warren et al., 1994). Similar to scl,
targeted deletion of lmo2 in mice demonstrated a require-
ment in primitive and definitive hematopoiesis and angio-
genesis, but not angioblast specification (Yamada et al.,
1998, 2000). Zebrafish scl and lmo2 are co-expressedspatiotemporally, and the scl+lmo2+ precursor cells in the
posterior lateral mesoderm differentiate to generate adjacent
but mutually exclusive hematopoietic (scl+lmo2+gata1+)
and endothelial (scl+lmo2+flk1+) populations (Davidson et
al., 2003; Gering et al., 1998). The expression of scl persists
in both cell types through approximately 28 hpf.
In contrast to the mouse studies described above,
previous functional analyses of scl in zebrafish have
suggested a role in the specification of hemangioblasts.
The zebrafish mutant, cloche (clo), displays a loss of
hematopoietic and endothelial tissue (Stainier et al., 1995).
Forced expression of scl in clo mutants rescues both
primitive erythroid and vascular gene expression (Liao et
al., 1998; Porcher et al., 1999), suggesting that scl functions
downstream of clo in specification of hemangioblasts. In
wild-type embryos, the expansion of posterior erythroid and
endothelial gene expression in response to scl occurs at the
expense of somitic mesoderm (Gering et al., 1998), and
forced co-expression of scl and lmo2 results in enhanced
induction of anterior endothelial gene expression at the
expense of cardiac mesoderm (Gering et al., 2003). Thus,
exogenous scl is able to reprogram mesodermal fate to
blood and endothelial tissue.
To date, mutations in the scl locus have not been
identified from large-scale mutagenesis screens in zebrafish,
precluding loss-of-function analyses. To investigate the
function of endogenous scl during zebrafish hematopoietic
and endothelial development, we created an scl knockdown
by utilizing site-directed, anti-sense morpholinos to inhibit
proper mRNA splicing. The results described demonstrate
that zebrafish scl is essential for the development of all
primitive and definitive hematopoietic lineages, but not for
the specification of angioblasts. When the scl morpholino
was injected into animals harboring an lmo2 promoter-green
fluorescent protein reporter transgene (Tg(lmo2:EGFP)),
allowing for visualization of vessel formation by GFP
fluorescence in live animals (Zhu et al., manuscript in
preparation), later defects in angiogenesis were observed.
The scl morphant phenotype is similar to that of Scl/
mice, and highlights the evolutionary conservation of scl
function. To further investigate the ability of exogenous scl
to induce endothelial gene expression, we over-expressed
scl in the zebrafish mutants, clo and spadetail (spt), a
bloodless mutant that displays abnormal posterior meso-
derm development (Griffin et al., 1998; Ho and Kane,
1990; Kimmel et al., 1989). In both clo and spt, a robust
induction of hematopoietic tissue was observed, whereas
the induction of endothelial tissue was attenuated. These
results strongly indicate that although scl has the ability to
induce both tissues, there are distinct requirements for
each. Interestingly, in clo, lmo2 was not induced upon scl
over-expression, indicating that scl can function independ-
ently of lmo2 when present in excess. Our findings
demonstrate that scl is normally required downstream of
hemangioblast formation for hematopoietic development
and angiogenesis.
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Fish husbandry
Zebrafish were maintained as described (Westerfield,
1993), and staged as described (Kimmel et al., 1995). Either
the Tq or WIK lines were used for all wild-type micro-
injection experiments. The radiation-induced sptb104 mutant
line was obtained from C. Kimmel (Eugene, OR) and the
spontaneous mutant clom39 was obtained from M. Fishman
(Charlestown, MA). The Tg(lmo2:EGFP) line has been
described (Zhu et al., manuscript in preparation).
Anti-sense morpholino knock down
The zebrafish scl intronic sequence was determined by
comparison of zebrafish scl cDNA sequence, fugu rubripes
genomic scl sequence (Barton et al., 2001), and the Sanger
Center zebrafish genome sequence database (http://www.
ensembl.org/Danio_rerio/). Anti-sense morpholino oligos
(Gene Tools, Corvalis, OR) were designed to target the
exon/intron boundary sequences of either exon 1 or exon 2
as follows: SCL E1/I: (5V-GCG GCG TTA CCT GTT AAT
AGT GGC G-3V); SCL E2/I: (5V-AAT GCT CTT ACC ATC
GTT GAT TTC-3V). As a control for specificity, a 4 base
pair mismatch was introduced into the SCL E1/I sequence
as follows: SCL E1/I.X (5V-GCA GCATTA CCT GTTACT
AGT AGC G-3V). Morpholinos were resuspended in
Danieau’s solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM
MgSO4, 0.6 mM Ca(NO3)2, 5.0 mM Hepes, pH7.6).
Embryos were microinjected at the 1–4 cell stage with 1
nl of morpholino, alone or in combination, at a final
concentration of 0.5 mM. Phenol Red was co-injected as a
tracer. The phenotypes observed for SCL E1/I alone, SCL
E2/I alone, or both morpholinos together were indistin-
guishable, as assessed by circulating blood cells in live
animals or in situ hybridization (ISH) for blood cell
markers. The results shown in all figures are for co-injection
of both SCL E2/I and SCL E1/I.
Whole mount RNA in situ hybridization
Digoxigenin (DIG)- or fluorescein (FLU)-labeled anti-
sense RNAs were transcribed from linearized templates
using RNA Labeling Kit (Sp6/T7) according to manufac-
turer’s protocol (Roche). Antisense riboprobes to scl (Liao
et al., 1998), gata1, gata2, (Detrich et al., 1995), be3 globin
(Brownlie et al., 2003), lmo2, c-myb, fli1, flk1 (Thompson
et al., 1998), fli1b (Zhu et al., manuscript in preparation),
efnb2 (Lawson et al., 2002), runx1 (Kalev-Zylinska et al.,
2002), draculin, l-plastin (Herbomel et al., 1999), rag2
(Willett et al., 1999), pu.1 (Lieschke et al., 2002),
mpo(Bennett et al., 2001), hhex (Ho et al., 1999), and
whnb (Schorpp et al., 2002), have been described pre-
viously. Whole mount RNA ISH were performed as
previously described (Ransom et al., 1996). DIG- or FLU-labeled riboprobes were detected using alkaline phosphatase
conjugated anti-DIG or anti-FLU antibodies (Roche),
followed by detection of alkaline phosphatase activity in
orange or blue using NBT/INT or NBT/BCIP substrate
(Sigma), respectively. For double ISH, the first color
reaction was inactivated by 2  15 min incubation in 100
mM Glycine, pH 2.2, following fixation in 4% PFA. After
inactivation, embryos were incubated in the second antibody
and processed as for single ISH. When necessary, embryos
raised to time points beyond 24 hpf were incubated in 0.8%
KOH/0.9% H2O2 for 15 min to remove pigment, followed
by 2 rinses in PBST, and re-fixation in 4% PFA.
Reverse transcriptase-PCR
RNA was harvested from pools of 20 embryos (unin-
jected or morpholino injected) at the 20-somite stage using
Trizol reagent according to the manufacturer’s protocol
(InVitrogen). First strand cDNA was prepared using Super-
script II RT according to the manufacturer’s protocol
(InVitrogen). PCR primers to amplify scl sequence were:
SCL seq10 (5V-TCC CAG AGA CCC GCT GAG CG-3V)
and SCL seq3 (5V-CAG GAG GGT GTG TTG GGATG-3V).
Control primers for eF1a were: EF1ADO (5V-ATA CCA
GCC TCA AAC TCA CC-3V) and EF1AUP (5V-ATC TAC
AAA TGC GGT GGA AT-3V).
RNA microinjection
Full length scl RNA was transcribed from linearized
pCS2+-SCLA2.1 (Liao et al., 1998; GenBank accession no.
AF045432) using mMessage mMachine according to
manufacturer’s protocol (Ambion). For morpholino rescue
experiments, 300 pg of scl RNA was injected separately,
immediately following the morpholino injection. Embryos
for microinjection of clo and spt mutants were obtained
from heterozygous incrosses, and 100 pg of scl mRNA was
injected between the 1- and 4-cell stages. Embryos were
fixed in 4% PFA for whole mount in situ hybridization.
Mutant spt embryos were identified morphologically.
Rescued clo embryos were genotyped using SSR marker
z1496 (Liao et al., 2000).Results
Loss of scl results in loss of all hematopoietic lineages
The role of scl in hematopoietic and endothelial develop-
ment was investigated by creating a knockdown using anti-
sense morpholinos targeted to the splice donor site of either
exon 1 or exon 2 of the zebrafish scl gene. Splice-site-
directed morpholinos inhibit pre-mRNA splicing events
(Draper et al., 2001), resulting in a loss of functional
mRNA. To visualize the aberrant scl message, reverse
transcriptase-PCR was performed on uninjected and mor-
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splice junctions of exons one and two (Fig. 1A). The
expected product of 325 bp was detected in uninjected,
control embryos, but not in scl morpholino-injected
embryos. Instead, aberrant products were observed, con-
firming the inhibition of proper pre-mRNA splicing in the
presence of the morpholinos. The expression of scl in the
scl morphant was further assessed by whole mount RNA in
situ hybridization. Detection of transcript levels was
drastically reduced at the 10-somite stage, and the reduction
persisted, shown here at the 20-somite stage (Figs. 1B–D).
The initial reduction in scl transcript is likely due to
nonsense mediated decay of the aberrant message, a process
known to occur in eukaryotes following transcription of
some nonsense alleles (reviewed in Mendell and Dietz,Fig. 1. Efficient knockdown of scl by morpholino injection. (A) Reverse-
transcriptase (RT)-PCR analysis of uninjected and scl morphant embryos.
An aberrant PCR product was observed in the scl morphant (+mo, lane 4)
compared to the 325-bp product observed in uninjected control embryos
(uninjected, lane 3). An approximate 325 bp product was observed with a
pCMV-scl plasmid control (plasmid ctl, lane 2), and no PCR product was
observed in the absence of template (, lane 1). The relative locations of
E1/I and E2/I are indicated as black bars in the schematic below, and the
relative locations of primers used for RT-PCR are indicated as arrows. As a
control, primers designed to amplify ef1-alpha yielded the same sized
product from uninjected or scl morphant embryos (lanes 5, 6). B–E) Whole
mount RNA in situ hybridization (ISH) for scl in uninjected (B, C) or scl
morphant embryos (D, E). In B and D, the yolk was removed and the 10-
somite embryos were flat mounted on glass slides for imaging. In C and E,
lateral views of the whole embryo at the 20-somite stage are shown. All
embryos are oriented with anterior to the left.2001; Wilkinson and Shyu, 2002). The presence of aberrant
transcripts as detected via non-quantitative RT-PCR and the
loss of scl transcripts as detected by whole mount RNA in
situ hybridization confirmed the effective knockdown of scl
via morpholino injection.
To investigate the role of scl in primitive erythroid
development, erythroid-specific gene expression was eval-
uated in the scl morphants. Transcripts for gata1, one of the
earliest known erythroid-specific genes, were undetectable
at the 10-somite stage in scl morphant embryos (n = 96/120;
80%) (Figs. 2A, B). To confirm that the loss of gata1 was
specific to the loss of scl, the scl morpholino was co-
injected with scl RNA. The exogenous RNA is unaffected
by splice-site directed morpholinos and should therefore
rescue the gata1 expression. Expression of gata1was
rescued in 100% of the co-injected embryos (n = 48). Of
these embryos, most had an asymmetric expression pattern
(n = 34/48; 71%), as shown in Fig. 2C, and the remaining
appeared wild type (n = 14/48; 29%). As a further control
for specificity, a 4-bp mismatch morpholino (E/I1.X) was
injected at the same or a two-fold higher dose as that of the
scl morpholino. All of the resulting embryos displayed
normal gata1 expression at the 10-somite stage at either
dose (n = 20/20 or n = 31/31, respectively; data not shown).
Therefore, the phenotype observed in the scl morpholino
injected embryos was specific to the loss of scl.
The genes runx1 and c-myb are expressed in primitive
hematopoietic cells within the bilateral stripes of the
posterior mesoderm (Burns et al., 2002; Thompson et al.,
1998). Morpholino knockdown of runx1 has suggested a
role in primitive hematopoiesis (Kalev-Zylinska et al.,
2002). In the scl morphant at approximately the 12 somite
stage, transcripts for runx1were not detected (n = 32/43;
75%), nor were transcripts for c-myb (n = 28/40; 70%)
(Figs. 2D–G), further demonstrating a defect at the earliest
stages of hematopoietic development. Later, the be3-
hemoglobin gene is normally expressed in differentiating
erythrocytes within the ICM as early as the 15-somite stage.
Consistent with the loss of gata1, transcripts for be3-
hemoglobin were undetectable (n = 59/61; 97%) in
morphant embryos (Figs. 2H, I). By the onset of circulation
at 28 hpf, qualitative assessment of circulating red blood
cells visualized under a dissecting microscope revealed an
absence of erythrocytes in the scl morphants (n = 93/97;
96%), in contrast to uninjected control animals (Figs. 2J, K).
This result was confirmed by the absence of hemoglobin as
detected by o-dianisidine staining (data not shown). There-
fore, the loss of scl inhibited the earliest stages of embryonic
erythroid development. In addition to the anemia, a mild
pericardial edema was evident from 28 hpf onward.
Otherwise, the overall morphology of the scl morpholino-
injected embryos was grossly normal at this time. By 2 days
post-fertilization (dpf), scl morphants display severe edema,
necrosis, and ultimately die between 6 and 7 dpf.
The function of scl in anterior primitive myelopoiesis
was evaluated by analyzing the expression of genes
Fig. 2. Loss of embryonic erythroid development in scl morphants. (A, B) Loss of gata1 expression as detected by ISH in the scl morphants at the 10-somite
stage. (C) Co-injection of 300 pg of scl RNA rescued the gata1 expression. Loss of transcripts for runx1 (D, E) and c-myb (F, G) at the 10 somite stage, and
be3-globin transcripts at 24 hpf (H, I), in scl morphants. (J, K) Absence of circulating erythroid cells in the scl morphant embryos (arrow), in comparison to
uninjected control embryos, as visualized under a dissecting microscope. Whole (A–C, H–I) or flat-mounted (D–G) embryos are shown with anterior to the left.
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pu.1, the granulocyte-specific gene, myeloperoxidase
(mpo), and the macrophage-specific gene, l-plastin,in the
scl morpholino injected embryos. Expression of pu.1 was
absent (n = 30/42; 71%) or strongly reduced (n = 9/42;
21%) in the scl morphants (Figs. 3A–C). In embryos with
a reduced amount of pu.1 expression, these cells remained
in the dorsal midline rather than migrating laterally over
the yolk sac as in uninjected embryos. Expression of
l-plastin at the 20-somite stage was strongly reduced (n =
12/35; 34%) or absent (n = 23/35; 66%) in morpholino-
injected embryos (Figs. 3D, E), and similar to results for
pu.1, in embryos that had a reduced amount of staining,
the l-plastin+ cells remained in the midline (data not
shown). Later, mpo expression at 40 hpf was also strongQ
ly reduced (n = 4/25; 16%) or absent (n = 21/25; 84%)
in the scl morphant embryos (Figs. 3F, G). In embryos
with reduced staining, the positive cells were located in
the posterior ventral tail region (data not shown). Thus,
loss of scl affected anterior hematopoiesis, resulting in aloss of differentiated primitive macrophage and monocyte
lineages.
Because the scl morphant survives to approximately 7
dpf, and definitive hematopoietic gene expression is
presumed to occur as early as 32 hpf, it was possible to
assess the effects of scl knockdown on definitive hema-
topoiesis. In the scl morphant, both runx1 (n = 18/26;
69%) and c-myb (n = 15/17; 88%) expression was
undetected at 36 hpf, suggesting a failure to form AGM-
derived HSCs (Figs. 4A–D). Consistent with a loss of
definitive HSCs, rag2 expression in the thymus was
undetectable (n = 40/40; 100%) in morpholino-injected
embryos (Figs. 4E, F). Failure to express rag2 was unlikely
to be the result of abnormal thymic development, since
expression of the whnb gene, which is expressed in thymic
epithelium (Schorpp et al., 2002), was unaffected (data not
shown). Thus, the knockdown of scl resulted in a loss of
primitive and definitive hematopoietic lineages, demon-
strating a key regulatory role for scl in hematopoietic
development.
Fig. 3. Loss of myeloid development in scl morphants. Transcripts for pu.1 were reduced (B) or absent (C) in the scl morphants, compared to uninjected
controls (C), as indicated by the arrows. l-plastin (D, E), and mpo transcripts were not detected in scl morphants. As a control, the mpo ISH was performed as a
double with be3-globin (be3) staining in red (F, G).
Fig. 4. Loss of definitive hematopoietic gene expression in scl morphants. Transcripts for runx1 (A, B), cmyb (C, D), and rag2 (E, F) were absent in scl
morphants. In A–D, arrow indicated the region of expression along the ventral wall of the dorsal aorta. In E and F, arrow indicates expression in the thymic
rudiment, ventral views.
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angioblast specification
If scl is required for the specification of hemangio-
blasts, the loss of scl should result in a loss of endothelial
cells. The genes, fli1, encoding an ets family transcription
factor (Brown et al., 2000), hhex, encoding a homeobox
transcription factor (Ho et al., 1999; Liao et al., 2000), and
flk1 (Liao et al., 1997), encoding a receptor tyrosine
kinase, are expressed in endothelial precursors as early as
the 10-somite stage, and by 24 hpf, these cells form the
axial and intersomitic vessels. In scl morpholino-injected
embryos at 26 hpf, fli1 and hhex were expressed in the
trunk region (Figs. 5A–D), indicating normal angioblast
specification. However, the angioblasts remain diffuse and
the axial and intersomitic vessels did not form [(n =22/24;
92%) and (n = 20/23; 87%), respectively], in comparison
to uninjected control embryos. The same results were
observed for analysis of flk1 expression (data not shown).
Consistent with the loss of vessel formation, the expression
of efnb2, a marker of the terminally differentiated dorsalFig. 5. Angiogenesis is disrupted in scl morphants. Transcripts for fli1 (A, B), hhex
arrowhead indicates the expression in intersomitic vessels, and in A, C, E–F, the ar
embryos, showing fluorescence in the axial and intersomitic vessels and blood ce
disruption of angiogenesis occurred. All images are lateral views of trunk regionaorta, was undetectable (n = 16/22; 73%) in the scl
morphants (Figs. 5E, F).
The later vascular defect was further demonstrated using
a transgenic line in which the lmo2 promoter directs GFP
expression in both hematopoietic and endothelial cells (Zhu
et al., manuscript in preparation), providing a means to
visually assess vessel formation in live embryos. In the
Tg(lmo2:EGFP) scl morphants, the axial vessels are
disorganized and very few intersomitic vessels were formed,
in contrast to uninjected, lmo2-GFP control embryos (Figs.
5G, H). At a higher morpholino concentration, the
intersomitic vessels were completely absent, and GFP+ cells
aggregated along the midline (Fig. 5I). The presence of GFP
expression in the Tg(lmo2:EGFP) scl morphants further
demonstrates that expression from the lmo2 promoter was
unaffected by the scl knockdown. These results confirm the
altered pattern of endothelial gene expression described
above, and further illustrate the disorganization of the
vasculature. Thus, scl is not required for angioblast
specification, but is necessary at a later stage for proper
angiogenesis.(C, D), and efnb2 (E, F) in uninjected and scl morphant embryos. In A, the
row indicates expression in the dorsal aorta. G) Uninjected Tg(lmo2:EGFP)
lls. In the presence of increasing amounts scl morpholino (H, I), increased
, anterior to the left.
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The absence of hematopoietic differentiation in the scl
morphant could be the result of a failure to specify HSCs
from mesoderm or a block in differentiation following HSC
specification. To further investigate these possibilities, the
expression of gata2 and lmo2, both of which are normally
co-expressed with scl as early as the 2–3 somite stage, was
evaluated. At the 12 somite stage, transcripts for both
gata2 (n = 39/39; 100%) and lmo2 (n = 35/35; 100%)
were expressed normally in the scl morphant embryos
(Figs. 6A–D), and their expression persisted until at least
the 20-somite stage (data not shown). Previous studies in
vitro have shown that gata2 and lmo2 are expressed in
Scl/ murine ES cells (Elefanty et al., 1997). Our results
extend these findings by demonstrating that, based on
anatomical location, the gata2+lmo2+ cells appear to
represent early hematopoietic cells blocked in further
differentiation due to the loss of scl.
To further evaluate the stage at which the scl knockdown
was inhibiting hematopoietic development, the expression
of draculin(dra) in the scl morphant was evaluated. The dra
gene encodes a novel zinc finger protein initially expressed
in early ventral mesoderm and later restricted to hema-
topoietic tissue in both the anterior and posterior mesoderm
(Herbomel et al., 1999). The function of dra remains
unclear. In scl morpholino-injected embryos, dra expression
at the 1-somite stage was normal (data not shown),
indicating proper development of ventral mesoderm. ByFig. 6. Analysis of early gene expression in the scl morphants. Expression of gata2
in scl morphants and uninjected controls. As an internal control, the gata2 ISH wa
in red (A, B). (I, J) Double ISH using probes for lmo2 (red arrow) and fli1b
magnification of posterior mesoderm. All embryos were flat mounted and show
embryos and regions of erythroid progenitors and angioblasts.the 10-somite stage, when dra expression is specific to the
hematopoietic tissue, its expression was either severely
decreased (n = 29/55; 53%) (Figs. 6E, F) or absent (n = 24/
55; 44%) in the scl morphants. By the 15-somite stage, dra
expression was not detected in the posterior nor anterior
hematopoietic mesoderm (data not shown). Therefore, the
temporal loss of dra expression provides further support
that scl is required for the maintenance or differentiation of
early hematopoietic precursors.
Previous results have demonstrated that forced expres-
sion of scl results in expansion of hematopoietic and
endothelial tissue at the expense of other mesodermal
derivatives, such as somitic and pronephric tissue (Gering
et al., 1998, 2003). It was therefore possible that cross-
antagonism between factors involved in tissue specification
could allow the permissive expansion of non-hematopoietic
mesodermal tissues in the scl morphant. Transcripts for
gata2 and lmo2 are present in endothelial cells, and to
confirm that the gata2+lmo2+ cells were not angioblasts, the
expression of fli1b was evaluated. The fli1b gene is one of
the paralogs of the ets-domain transcription factor fli1, and
is specifically expressed in endothelial cells (Zhu et al.,
manuscript in preparation). The expression pattern of fli1b
appeared normal (n = 28/28; 100%) in scl morphant
embryos (Figs. 6G, H). Double ISH with lmo2 and fli1b
further illustrated that endothelial fate was not expanded in
the scl morphant, relative to wild type (Figs. 6I, J).
Similarly, the expression pattern of pax2.1, a pronephric
duct marker, appeared normal in the scl morphant (data not(A, B), lmo2 (C, D), dra (E, F) and fli1b (I, J) at the 10- to 12-somite stage
s performed as a double with myoD, a marker of the somitic tissue, detected
(green arrow) in uninjected and scl morphant embryo, showing higher
n with anterior to the left. In D, a schematic illustrates the orientation of
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expanded, and cells with an early hematopoietic identity
were specified in the absence of scl.
Forced expression of scl in wild type, clo and spt reveals
separable effects on hematopoietic and vascular tissue
To further investigate the differences between the loss-
of-function phenotype described here and the previously
reported gain-of-function effects (Gering et al., 1998, 2003;
Liao et al., 1998), we injected scl RNA into wild-type and
mutant embryos. In wild-type embryos, forced expression of
scl resulted in an increase in both gata1 and flk1 expression
(Figs. 7A, B) and a concomitant loss of myoD+ somitic
tissue (Figs. 7C, D), consistent with previously reported
results. Using double RNA ISH, we further demonstrated
that the expansion of gata1+ and flk1+ tissue was spatially
distinct and non-overlapping; the gata1 expression domain
expanded laterally, while the flk1 expression domain
expanded medially. This suggested that scl may function
independently within the two tissue domains to achieve
induction.
The spt mutant was utilized to further address the role of
somitic mesoderm in the expansion of hematopoietic and
endothelial tissue described above. The spt mutant has a
severe loss of trunk somitic mesoderm and a loss of
posterior hematopoietic cells, while initial specification of
angioblasts appears relatively normal (Griffin et al., 1998;Fig. 7. Forced expression of scl RNA in wild-type and spadetail mutants. (A, B
injected (B) embryos. (C, D) myoD transcripts normally present in adaxial cells (bl
embryos. (E–H) The expression of gata1 (E, F) or flk1 (G, H) in uninjected (E, G)
mesoderm; arrow indicates flk1 expression in posterior mesoderm; arrowhead indKimmel et al., 1989; Rohde et al., 2004; Thompson et al.,
1998; Weinberg et al., 1996). If the induction of either
hematopoietic or endothelial tissues in response to forced
expression of scl occurs at the expense of somitic
mesoderm, the induction might be attenuated in spt mutants.
In spt/ embryos, scl RNA injection resulted in an efficient
induction of gata1 expression, when compared to unin-
jected spt/ embryos, which have no detectable gata1
expression (Figs. 7E, F). In contrast, an expansion of flk1
expression in the posterior lateral mesoderm was not
observed, relative to uninjected spt/ controls (arrows,
Figs. 7G, H). A slight increase in the anterior flk1
expression and an altered pattern in the posterior tail bud
were observed. This altered flk1 expression pattern in the
tail bud was not observed in scl RNA injected wild-type
embryos. Thus, an absence of somitic tissue correlated with
an inability of scl to induce endothelial, but not hema-
topoietic tissue, in the posterior mesoderm.
The clo mutant has a loss of hematopoietic and
endothelial tissue, but normal somitic mesoderm (Stainier
et al., 1995). Upon forced expression of scl in clo mutants,
an expansion of hematopoietic and endothelial tissue and a
concomitant loss of somitic tissue might be expected,
similar to results in wild-type embryos. In the clo/
embryos, scl RNA injection resulted in an efficient
expansion of gata1 expression (Figs. 8C, D), comparable
to that observed in wild-type embryos (Figs. 8A, B). In
contrast, only a very modest induction of flk1 expression) Double ISH for flk1 (blue) or gata1 (red) in uninjected (A) or scl RNA
ack arrow) and somites (blue arrow) are not detected in the scl RNA injected
or scl RNA injected (F, H) spt/ embryos. Brackets indicate anterior head
icates tail bud. All embryos are at the 12-somite stage.
K.A. Dooley et al. / Developmental Biology 277 (2005) 522–536 531was observed in the posterior mesoderm (Figs. 8G, H),
particularly evident when compared to the induction in
wild-type embryos (Figs. 8E, F). In the anterior mesoderm
of injected clo/ embryos, an efficient induction of flk1
expression was observed. In addition, a less dramatic loss in
somitic tissue upon scl RNA injection was observed in
clo/-injected embryos (Figs. 8A–D).
To further investigate the observed differences in
endothelial versus hematopoietic induction in clo, expres-
sion of gata2 and lmo2 was evaluated following scl RNA
injection. In wild-type embryos, a strong induction of gata2
was observed following scl RNA injection (Figs. 8I, J). In
clo/ embryos, gata2 expression is normally very low, and
only just detectable in the most posterior mesoderm. Upon
scl over expression, gata2 is induced (Figs. 8K, L),
although to a lesser degree than observed in wild-type
embryos. A decrease in myoD expression is also visible, as
shown (Fig. 8L). In wild-type embryos, a robust expansion
of lmo2 is observed following scl over expression (Figs.
8M, N). This effect was also observed earlier, at the 5-
somite stage (data not shown) and later, at the 20-somite
stage (Fig. 8Q, R). Surprisingly, in clo/-injected embryos,
lmo2 was not induced at any of the stages observed (Figs.
8O, P, S, T, and data not shown), despite the robust
induction of gata1. Thus, in clo, scl is capable of inducing
hematopoietic tissue independently of endothelial tissue,
and in the absence of lmo2.Fig. 8. Analysis of hematopoietic and endothelial expansion in clo in response to
gata1, gata2, or lmo2 in blue, or single ISH using flk1 (E–H) or lmo2 (Q–T), in
controls, as indicated. In G, H, brackets indicate anterior endothelial cells, and ar
expression of flk1 in the tail bud. Embryos are between the 10- and 12-somite stBecause previous rescue experiments place scl down-
stream of clo in hematopoietic and endothelial development
(Liao et al., 1998), it is of interest to compare early gene
expression in the scl morphant to that of clo. In the scl
morphant, both lmo2 and gata2 expression was comparable
to that of wild type, as described above (Figs. 6A–D). In clo
at the 10 somite stage, the expression of gata2 was
dramatically reduced, with only a few cells in the most
posterior bilateral mesoderm showing expression (Fig. 8K).
The expression of lmo2 at the 10-somite stage in clo was
greatly reduced and only present in the most lateral of the
posterior stripes (Fig. 8O). Double ISH with the pronephric
marker, pax2.1 indicates that this represents pronephric
tissue (our unpublished results). Together, these results
extend previous findings and demonstrate that the loss of
lmo2 and gata2 during early embryogenesis in clo is not
due to the loss of scl.
The results are summarized in Fig. 9. The induction or
expansion of gata1 expression in response to scl RNA did
not require a loss of somitic tissue, since the observed
effects occurred in spt/ embryos, which lack trunk
somitic mesoderm. In contrast, the expansion of endothelial
tissue was attenuated in spt/ and clo/ embryos. In
clo/, the lack of posterior expansion of endothelial tissue
correlated with an inability to induce lmo2. Interestingly,
despite the lack of lmo2, a robust induction of gata1
expression occurred in response to exogenous scl. Theseforced expression of scl. Double ISH (A–D, I–P) using myoD in red and
wild-type and clo/ embryos injected with scl RNA (+scl) or uninjected
rows indicate posterior lateral mesoderm. In (I and J) arrowhead indicates
age (A–P) or the 20 somite stage (Q–T).
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hematopoietic and endothelial development in response to
forced expression of scl.Discussion
Our results demonstrate that zebrafish scl is necessary for
primitive and definitive hematopoietic development and for
angiogenesis. Angioblasts were specified normally in the scl
morphants, demonstrating that hemangioblast formation
was unaffected. Our analyses in clo and spt indicate that
the ability of scl to expand both hematopoietic and
endothelial tissue is separable, and further, demonstrate that
scl is capable of inducing hematopoietic gene expression
independent of lmo2.
The absence of multi-lineage hematopoiesis observed in
the scl morphant is likely due to a requirement in HSCs or
early progenitor cells, rather than a requirement for scl in
each of the differentiated lineages, by analogy to recent
studies of conditional scl knockdown in mice (Mikkola et
al., 2003). These studies demonstrated that following
specification of HSCs, Scl is required for proper differ-
entiation of the erythroid and megakaryocyte lineages, but
not lymphoid or myeloid lineages. Furthermore, in zebra-
fish, anterior myelopoiesis occurs independently of poste-
rior ICM erythropoiesis, as spt and kugelig (kgg) mutants
lack ICM hematopoiesis but have normal anterior myeloidFig. 9. Summary of scl gain- and loss-of-function phenotypes in wild type, spt, an
tissue, while endothelial and somitic tissues are unaffected. (B) In wild-type embry
hematopoietic (red) and endothelial tissue (green) at the expense of somitic tissue
Upon forced expression of scl RNA, an expansion of hematopoietic but not endoth
endothelial tissue but have normal somitic tissue. Upon forced expression of sc
expansion of endothelial tissue, occurred. Somites are slightly less affected in injdevelopment (Davidson et al., 2003; Lieschke et al., 2002).
In both spt and kgg mutants, scl expression is absent in the
posterior hematopoietic region but normal in the anterior
hematopoietic region, correlating with the hematopoietic
phenotypes. Our results demonstrate that, although posterior
erythroid and anterior myeloid development can occur
independently, both require scl, presumably in HSCs or
early progenitor cells.
Transcripts for gata2 and lmo2 were unaffected in the scl
morphant, despite the loss of molecular markers for more
differentiated hematopoietic lineages. Gene expression
profiling of in vitro differentiated Scl/ murine ES cells
have also shown gata2 and lmo2 expression comparable to
that of differentiated wild-type ES cells (Elefanty et al.,
1997). Both gata2 and lmo2 are also expressed in early
endothelial cells. In the scl morphant, embryonic patterning
was normal as assessed by both morphology and tissue-
specific gene expression. The ability to observe normal
gata2 and lmo2 expression in the embryo proper suggests
that mesodermal cells have committed to a hematopoietic
fate, but in the absence of scl, are blocked in further
differentiation. The temporal loss of dra expression in the
scl morphant further indicates a block in differentiation or
maintenance. The fate of the gata2+lmo2+ presumptive
hematopoietic precursors is unclear. An increase in apopto-
sis as detected by acridine orange staining was not observed
through to the 20-somite stage (data not shown), but it is
possible that these cells undergo apoptosis at a later stage ofd clo. (A) In the scl morphant, loss of scl results in a loss of hematopoietic
os, forced expression of scl RNA results in mutually exclusive expansion of
(yellow). (C) spt/ embryos lack hematopoietic and trunk somitic tissue.
elial tissue was observed. (D) clo/ embryos lack both hematopoietic and
l RNA, an efficient expansion of hematopoietic tissue, but only a modest
ected clo/ embryos than in injected wild-type embryos.
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induction and patterning of hematopoietic tissue in the
lateral mesoderm occurs normally in the absence of scl, but
a later defect occurs within the HSCs or progenitor cells as
assessed by a loss of more differentiated molecular markers.
The loss of definitive HSCs in the scl morphant was
concluded from the loss of runx1 and cmyb expression at 36
hpf in the AGM region. The defect in vascular remodeling is
evident at this time, and the lack of AGM HSCs could be a
secondary effect due to the loss of a correctly organized
dorsal aorta. In mice, chimeric analyses showed that Scl/
cells do not contribute to definitive hematopoietic lineages,
demonstrating a cell autonomous role for scl in making
definitive HSC (Porcher et al., 1996; Robb et al., 1996). By
analogy, these observations suggest that the loss of AGM
HSCs was the result of the absence of scl. However,
because of the role of scl in vascular remodeling, a further
evaluation of the requirement for scl in definitive HSC
formation awaits the advent of conditional gene targeting
techniques in the zebrafish.
The specification of angioblasts occurred normally in the
scl morphant. Because forced expression of scl is capable of
partially rescuing both hematopoietic and endothelial gene
expression in clo (Liao et al., 1998), it has been
hypothesized that scl is required for hemangioblast speci-
fication. Based on the normal expression of endothelial
genes in the scl morphant, the loss of endothelial gene
expression in clo is independent of scl. The loss of lmo2 and
gata2 in clo also appears to be independent of the loss of
scl, as the scl morphant displayed normal lmo2 and gata2
expression. It has previously been demonstrated that forced
expression of scl can induce lmo2 and gata2 expression
(Gering et al., 2003). Our results demonstrate that although
scl is sufficient to induce expression of gata2, lmo2, and
endothelial genes, as discussed further below, their expres-
sion does not require scl.
A defect in angiogenesis was observed in the scl
morphant, despite normal specification of angioblasts, and
the Tg(lmo2:EGFP) line allowed real time visualization of
this defect. The vascular defect in the scl morphant is
likely to be cell autonomous, as scl is expressed in
vascular cells until 26 hpf. A cell non-autonomous defect
from loss of a hematopoietic derived signal is unlikely, as
mutants that lack circulating erythrocytes, such as blood-
less and vlad tepes, develop normal vasculature (Liao et
al., 2002; Lyons et al., 2002). The vascular phenotype in
the scl morphant is similar to that reported for the flk1
mutant (Habeck et al., 2000), the VEGF-A morphant
(Nasevicius et al., 2000), and the phospholipase C gamma-
1 (plcg1) mutant (Lawson et al., 2003). The VEGF
molecule signals through flk1, and plcg1 is thought to
function as effector of this signaling pathway in vessel
formation. In addition to its role in vascular development,
VEGF signaling has been reported to stimulate hematopoi-
esis and scl expression (Liang et al., 2001; Martin et al.,
2004). Further studies are needed to address the role of sclin vascular remodeling and its relationship to the VEGF
signaling pathway in this process.
Forced expression of scl in wild-type embryos resulted in
the expansion of mutually exclusive populations of both
hematopoietic and endothelial cells at the expense of
somitic mesoderm. One model to explain this observation
is that of an expansion of a bipotential hemangioblast
population, followed by migration and differentiation to
distinct fates in response to spatially restricted environ-
mental signals. An alternative model is that of a functionally
independent expansion of both tissues in response to forced
expression of scl. By utilizing the spt and clo mutants, we
provide evidence to support the latter possibility. Under
normal conditions, angioblasts are specified in spt, as
evidenced by flk1 expression (Rohde et al., 2004; Thomp-
son et al., 1998). Upon forced expression of scl in spt, the
posterior flk1+ endothelial tissue was not expanded, while
gata1+ hematopoietic tissue was induced. Thus, the
expansion of endothelial tissue in response to forced
expression of scl required trunk somitic tissue, or another
spt dependent factor, whereas expansion of hematopoietic
tissue did not.
Under normal conditions, gata1 and flk1 are only very
weakly expressed in clo mutants. Upon forced expression
of scl in clo mutants, gata1 expression was robustly
expanded, whereas only a very slight induction of flk1
expression within the posterior mesoderm was observed.
Previously, scl was reported to rescue flk1 expression at 24
hpf in clo (Liao et al., 1998). The number of flk1+ cells
present at the 10-somite stage following scl RNA injection
may proliferate to generate the phenotype observed at 24
hpf, or alternatively, there may be a second wave of
angioblast specification that is more efficiently rescued by
forced expression of scl. In the rescued clo embryos, the
somitic tissue was slightly less affected by over-expression
of scl than it was in wild-type embryos, possibly reflecting
the less efficient induction of endothelial tissue. Taken
together, the analyses in the mutant backgrounds supports a
model where scl is capable of inducing both hematopoietic
and endothelial tissue via functionally independent mech-
anisms, and only the latter is attenuated in a clo- and spt-
dependent manner.
Interestingly, lmo2 was not induced in clo mutants in
response to scl. This was unexpected, as murine lmo2,
similar to scl, is essential for primitive and definitive
hematopoiesis (Warren et al., 1994; Yamada et al., 1998). It
is likely that endogenous lmo2 is normally required for
zebrafish hematopoiesis. However, under conditions where
scl is present in vast excess, the requirement for such a co-
factor could be overcome. Alternatively, it is possible that
there is a compensatory upregulation of another LIM
domain protein, such as lmo1 or lmo4, which can then
interact with scl in place of lmo2. In addition, the observed
antagonism between mesodermal fates could be due to an
ability of scl to squelch non-specific transcription factors or
an ability to interact with other bHLH factors required for
K.A. Dooley et al. / Developmental Biology 277 (2005) 522–536534tissue differentiation, such as myoD (reviewed in (Rudnicki
and Jaenisch, 1995) and interfere with their function. It has
recently been shown that SCL is capable of transforming
mouse T cells in the absence of LMO2 by interfering with
the function of the bHLH proteins, E47 and HEB (O’Neil et
al., 2004). The ability of scl to both induce blood and alter
the fate of other mesodermal derivatives could be the result
of the combined effects of such mechanisms. Further
investigation of zebrafish scl and lmo proteins will
distinguish between these possibilities.
The inability of scl to induce flk1 expression in the
posterior mesoderm of clo mutants correlates with the
inability to induce lmo2, and is an intriguing possible
explanation for this effect. However, in contrast to the
posterior mesoderm, a rescue of flk1 expression was
observed in the anterior mesoderm, despite the lack of
lmo2 in this region. Previous analyses of forced co-
expression of scl and lmo2 in wild-type embryos demon-
strated that an expansion of anterior endothelial tissue
correlated with a loss of anterior cardiac mesoderm (Gering
et al., 2003). With scl over-expression alone, we did not
observe a loss of the cardiac marker, nkx2.5 (data not
shown). Additionally, spt/ embryos do express lmo2 in
the posterior endothelial mesoderm (Rohde et al., 2004;
Thompson et al., 1998), and is presumably not the reason
for the inability of scl to induce flk1 in these embryos.
To date, large-scale mutagenesis screens in zebrafish
have failed to identify mutations in the scl locus. The
reason for this is unclear, since the scl morphant survives
beyond the time at which previous genetic screens for
hematopoietic mutants have been performed (Ransom et al.,
1996; Weinstein et al., 1996; Dooley, K, Davidson, AJ,
Schmid, B, Tq 200 Screen Consortium, and Zon, LI.,
unpublished results). In the absence of a genetic mutant, we
utilized morpholino knockdown technology and have
demonstrated that zebrafish scl is important for hemato-
poietic development and angiogenesis, highlighting the
evolutionary conservation of scl function. Together with
over-expression analyses in zebrafish mutants, these results
argue against a role for scl in the specification of
hemangioblasts. To date, little is know about the targets
of scl (Cohen-Kaminsky et al., 1998; Xu et al., 2003),
either in hematopoietic or later endothelial development.
The efficient knockdown of scl by morpholino injection
provides a valuable tool for further analysis of in vivo
targets of scl in both hematopoietic development and
vascular remodeling.Acknowledgments
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